![](https://imageio.forbes.com/specials-images/imageserve/668ed981b9eaffa37129a571/0x0.jpg?format=jpg&crop=3749,2111,x0,y122,safe&height=900&width=1600&fit=bounds)
FTC Will Sue Pharmacy Middlemen Over Inflated Insulin Prices, Report Says
Topline The Federal Trade Commission will sue three of the largest pharmacy benefit managers after the agency released a report alleging the companies—which manage roughly 80% of prescriptions in the U.S.—were driving up the prices of some medications, …